| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CONNECTURE INC | 5,502,965 | 56,956,000 | 25.07% | ||
| 2 | HYPERION THERAPEUTICS INC | 500,000 | 22,950,000 | 10.10% | ||
| 3 | VANDA PHARMACEUTICALS INC | 1,388,599 | 12,914,000 | 5.68% | ||
| 4 | ORTHOFIX INTERNATIONAL NV | 300,000 | 10,767,000 | 4.74% | ||
| 5 | Adamas Pharmaceuticals Inc | 608,650 | 10,645,000 | 4.68% | ||
| 6 | OCERA THERAPEUTICS INC | 1,963,777 | 9,249,000 | 4.07% | ||
| 7 | Alimera Sciences, Inc | 1,731,550 | 8,675,000 | 3.82% | ||
| 8 | AURINIA PHARMACEUTICALS INC | 1,941,144 | 8,511,000 | 3.75% | ||
| 9 | DERMA SCIENCES INC COM PAR .01 | 977,923 | 8,283,000 | 3.65% | ||
| 10 | VERICEL CORP | 2,086,028 | 7,718,000 | 3.40% | ||
| 11 | Versartis Inc | 385,000 | 7,072,000 | 3.11% | ||
| 12 | Sucampo Pharmaceuticals Inc | 450,000 | 7,002,000 | 3.08% | ||
| 13 | STEMLINE THERAPEUTICS INC | 475,200 | 6,877,000 | 3.03% | ||
| 14 | ARADIGM CORP | 1,002,962 | 6,338,000 | 2.79% | ||
| 15 | ASCENDIS PHARMA A S | 339,863 | 5,896,000 | 2.59% | ||
| 16 | Alcobra Ltd | 983,786 | 5,539,000 | 2.44% | ||
| 17 | DYAX CORP COM CVR | 235,950 | 3,953,000 | 1.74% | ||
| 18 | HERON THERAPEUTICS INC | 270,000 | 3,929,000 | 1.73% | ||
| 19 | TENAX THERAPEUTICS INC | 1,108,593 | 3,614,000 | 1.59% | ||
| 20 | AMPIO PHARMACEUTICALS INC | 421,500 | 3,174,000 | 1.40% | Put | |
| 21 | Enanta Pharmaceuticals Inc | 100,000 | 3,062,000 | 1.35% | ||
| 22 | Emergent BioSolutions Inc | 102,791 | 2,956,000 | 1.30% | ||
| 23 | Sunesis Pharmaceuticals I | 1,038,652 | 2,545,000 | 1.12% | ||
| 24 | ATHERSYS INC | 830,200 | 2,391,000 | 1.05% | Call | |
| 25 | STRATA SKIN SCIENCES INC COM | 569,591 | 1,464,000 | 0.64% | ||
| 26 | BELLICUM PHARMACEUTICALS INC | 50,000 | 1,159,000 | 0.51% | ||
| 27 | BOVIE MEDICAL CORP | 480,000 | 1,147,000 | 0.50% | ||
| 28 | Vical Inc | 846,762 | 800,000 | 0.35% | ||
| 29 | STREAMLINE HEALTH SOLUTIONS | 151,611 | 538,000 | 0.24% | ||
| 30 | VERACYTE INC | 68,158 | 497,000 | 0.22% | ||
| 31 | ATHERSYS INC | 100,000 | 288,000 | 0.13% | Put | |
| 32 | OSIRIS THERAPEUTICS INC NEW | 12,165 | 214,000 | 0.09% | ||
| 33 | MEI PHARMA INC | 52,254 | 94,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000930413-15-002517, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
